Pharmacology and toxicology of the novel investigational agent Cantrixil (TRX-E-002-1)

PURPOSE: Recurrent, chemo-resistant ovarian cancer is thought to be due to a subgroup of slow-growing, drug-resistant cancer cells with stem-like properties and a high capacity for tumour repair. Cantrixil targets this sub-population of cells and is being developed as an intraperitoneal therapy to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Saif, Muhammad Wasif, Heaton, Andrew, Lilischkis, Kimberley, Garner, James, Brown, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306062/
https://www.ncbi.nlm.nih.gov/pubmed/28013349
http://dx.doi.org/10.1007/s00280-016-3224-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306062/
https://www.ncbi.nlm.nih.gov/pubmed/28013349
http://dx.doi.org/10.1007/s00280-016-3224-2

Ejemplares similares